|
Stem cell origin of myelodysplastic syndromes
|
Dec 2013
|
Oncogene
|
myelodysplastic syndromes (MDS)
|
|
Stem Cell Transplant from Unrelated Donor in Patients with Severe Aplastic Anemia: Indications, Donor Selection, Conditioning, GVHD Prophylaxis
|
Feb 2015
|
Curr Drug Targets
|
aplastic anemia
|
|
Stem cell transplants for myelodysplastic syndromes: refining the outcome predictions
|
Oct 2014
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
|
Striking the right balance: optimizing conditioning regimens for unrelated donor bone marrow transplant for severe aplastic anemia.
|
May 2012
|
Biol Blood Marrow Transplant
|
aplastic anemia
|
|
Successful pregnancy outcome in paroxysmal nocturnal hemoglobinuria (PNH) following escalated eculizumab dosing to control breakthrough hemolysis
|
May 2015
|
Leuk Res Rep
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Successful treatment of aplastic anemia-paroxysmal nocturnal hemoglobinuria associated with eosinophilic fasciitis with matched unrelated donor allogeneic peripheral blood stem cell transplantation
|
Jul 2016
|
Clin Case Rep
|
aplastic anemia
|
|
Successful Treatment of Ascites using a Denver<sup>®</sup> Peritoneovenous Shunt in a Patient with Paroxysmal Nocturnal Hemoglobinuria and Budd-Chiari syndrome
|
Oct 2016
|
Intern Med
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Successful Use of Eculizumab in a Pediatric Patient Treated for Paroxysmal Nocturnal Hemoglobinuria
|
Jul 2012
|
J Pediatr Hematol Oncol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Supportive care in severe and very severe aplastic anemia
|
Dec 2012
|
Bone Marrow Transplant
|
aplastic anemia
|
|
Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes
|
Dec 2020
|
Hematology/oncology and stem cell therapy
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
